GWM
ANVS icon

Greenwich Wealth Management’s Annovis Bio ANVS Stock Holding History

Greenwich Wealth Management’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$105K Buy
47,000
+4,600
+11% +$12.6K ﹤0.01% 298
2025
Q4 		$147K Sell
42,400
-5,000
-11% -$15K 0.01% 278
2025
Q3 		$98K Buy
47,400
+400
+0.9% +$1K ﹤0.01% 270
2025
Q2 		$102K Buy
47,000
+900
+2% +$1.78K 0.01% 243
2025
Q1 		$69K Buy
46,100
+14,149
+44% +$43.3K 0.01% 234
2024
Q4 		$161K Buy
31,951
+15,476
+94% +$112K 0.01% 244
2024
Q3 		$133K Buy
16,475
+1,400
+9% +$13.1K 0.01% 236
2024
Q2 		$87K Buy
15,075
+2,500
+20% +$20.3K 0.01% 234
2024
Q1 		$150K Buy
12,575
+2,300
+22% +$25.1K 0.01% 229
2023
Q4 		$192K Buy
+10,275
New +$91.1K 0.02% 218

Other funds holding ANVS

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Greenwich Wealth Management's ANVS Position: Q1 2026 in Review

Greenwich Wealth Management increased its Annovis Bio (ANVS) stake by 11% in Q1 2026, buying an estimated $12.6K and bringing the position to 47,000 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #298.

Greenwich Wealth Management first reported a position in ANVS in Q4 2023 and has held it in 10 quarters since. The position peaked at $192K in Q4 2023. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

  • Greenwich Wealth Management held 47,000 shares of Annovis Bio worth $105K as of Q1 2026.
  • Greenwich Wealth Management bought 4,600 Annovis Bio shares in Q1 2026, an estimated $12.6K.
  • Annovis Bio made up ﹤0.01% of Greenwich Wealth Management's portfolio in Q1 2026, its #298 holding.
  • Greenwich Wealth Management first reported a position in Annovis Bio in Q4 2023 and has held it in 10 quarters since.
  • Greenwich Wealth Management's Annovis Bio position peaked at $192K in Q4 2023.
  • 56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on Greenwich Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.